Ieuan Davies
Papers
2
Total Citations
70
H-Index
2
About
Ieuan Davies is a analytical chemist whose research has made significant contributions to the field of oncological pharmacology, particularly in the development of advanced methods for monitoring anti-cancer drugs in biological systems. His work has focused on applying cutting-edge analytical techniques — specifically automated solid-phase extraction combined with liquid chromatography–tandem mass spectrometry (LC-MS/MS) — to accurately and rapidly quantify chemotherapeutic agents in human serum and plasma. Davies's most influential contribution, published in 1999, established a robust methodology for detecting the alkylating agent chlorambucil and its key metabolite, phenylacetic acid mustard, in patient samples, accumulating 49 citations and becoming a foundational reference in therapeutic drug monitoring. Building on this success, his 2000 study extended the same sophisticated analytical framework to melphalan, another critical alkylating chemotherapy agent, further demonstrating the versatility and clinical utility of his approach. His research holds particular importance for improving patient care, as precise quantification of these drugs enables clinicians to optimize dosing, minimize toxicity, and better understand drug metabolism. Davies's methodological innovations continue to inform both clinical practice and pharmaceutical research in cancer treatment monitoring.
Research Focus
Key Achievements
Top Papers
- 1
- 2